top of page
Patient Survey

 

To make this Risk Management Educational Program more effective, Dr Reddy’s Laboratories Canada Inc. is conducting this survey and your participation is requested. Your answers will not affect your ability to receive HANZEMA™ (alitretinoin). Your answers and personal information will be kept confidential and anonymous.

Are you a female of child bearing years?
Where did you receive/access the Hanzemaâ„¢ (alitretinoin) education materials?
Have you ever used the Hanzemaâ„¢ (alitretinoin) website to access the education materials?
If you answered yes to the question above, was it easier to read information on the website or printed material?
Did you need to speak to your physician or pharmacist in order to better understand the risks associated with Hanzemaâ„¢ (alitretinoin) after reading the educational material?
Did you find the information provided in the educational material sufficient and helpful for you to decide if you can comply with the requirements of this risk management program for Hanzemaâ„¢ (alitretinoin)?

Thanks for submitting!

bottom of page